We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.36B
AUM Growth
-$1.68B
Cap. Flow
-$1.45B
Cap. Flow %
-43.28%
Top 10 Hldgs %
28.65%
Holding
6,080
New
399
Increased
1,937
Reduced
2,718
Closed
947

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$126M
2
NVDA icon
NVIDIA
NVDA
+$101M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$97.8M
4
MSFT icon
Microsoft
MSFT
+$89.5M
5
AMZN icon
Amazon
AMZN
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 19.97%
2 Financials 9.87%
3 Consumer Discretionary 8.34%
4 Healthcare 7.98%
5 Communication Services 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LUNG icon
2626
Pulmonx
LUNG
$104M
$29.5K ﹤0.01%
4,380
-2,053
-32% -$14.5K
SDA icon
2627
SunCar Technology Group
SDA
$77.6M
$29.4K ﹤0.01%
7,147
+5,205
+268% +$34.3K
ABX
2628
Abacus Global Management
ABX
$907M
$29.4K ﹤0.01%
3,931
+1,021
+35% +$7.75K
NSSC icon
2629
Napco Security Technologies
NSSC
$1.37B
$29.4K ﹤0.01%
1,279
+586
+85% +$16.6K
ATRC icon
2630
AtriCure
ATRC
$2.25B
$29.4K ﹤0.01%
911
-1,960
-68% -$72.8K
CLOV icon
2631
Clover Health Investments
CLOV
$2.44B
$29.4K ﹤0.01%
8,186
-37,900
-82% -$152K
TRUP icon
2632
Trupanion
TRUP
$1.34B
$29.4K ﹤0.01%
805
+377
+88% +$15.7K
OSG
2633
Octave Specialty Group
OSG
$221M
$29.3K ﹤0.01%
3,348
+666
+25% +$7.01K
NRIM icon
2634
Northrim BanCorp
NRIM
$606M
$29.3K ﹤0.01%
1,600
+136
+9% +$2.69K
DYN icon
2635
Dyne Therapeutics
DYN
$4.8B
$29.3K ﹤0.01%
2,798
-13,220
-83% -$189K
NWN icon
2636
Northwest Natural Holdings
NWN
$2.14B
$29.3K ﹤0.01%
685
-2,145
-76% -$87.4K
DOLE icon
2637
Dole
DOLE
$1.26B
$29.3K ﹤0.01%
2,025
+640
+46% +$8.84K
MTLS
2638
Materialise
MTLS
$400M
$29.2K ﹤0.01%
5,942
+4,470
+304% +$30.7K
LMAT icon
2639
LeMaitre Vascular
LMAT
$1.88B
$29.2K ﹤0.01%
348
-4,298
-93% -$400K
VVX icon
2640
V2X
VVX
$2.6B
$29.1K ﹤0.01%
594
-9,585
-94% -$470K
GRAL
2641
GRAIL Inc
GRAL
$3.03B
$29.1K ﹤0.01%
1,138
-14,167
-93% -$438K
KW
2642
DELISTED
Kennedy-Wilson Holdings
KW
$29K ﹤0.01%
3,344
+604
+22% +$5.5K
TBI
2643
Trueblue
TBI
$311M
$29K ﹤0.01%
5,466
+1,632
+43% +$11.1K
INSP icon
2644
Inspire Medical Systems
INSP
$1.65B
$29K ﹤0.01%
182
-1,093
-86% -$198K
CRGX
2645
DELISTED
CARGO Therapeutics
CRGX
$28.9K ﹤0.01%
7,113
+1,313
+23% +$8.79K
SNDR icon
2646
Schneider National
SNDR
$6.33B
$28.9K ﹤0.01%
1,266
-9,023
-88% -$244K
GNK icon
2647
Genco Shipping & Trading
GNK
$1.15B
$28.9K ﹤0.01%
2,162
-921
-30% -$13.1K
ETWO
2648
DELISTED
E2open Parent Holdings
ETWO
$28.9K ﹤0.01%
14,439
+8,052
+126% +$20K
CALY
2649
Callaway Golf Company
CALY
$2.94B
$28.8K ﹤0.01%
4,366
+2,156
+98% +$15.8K
VGIT icon
2650
Vanguard Intermediate-Term Treasury ETF
VGIT
$42.4B
$28.8K ﹤0.01%
+484
New +$28.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2025 Portfolio in Review

As of Q1 2025, Tower Research Capital (TRC) held 6,080 positions worth $3.36B, down 33% from $5.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.45B in Q1 2025, closing 947 positions and reducing 2,718 holdings. Its most notable exit was Listed Funds Trust Roundhill Magnificent Seven ETF, an estimated $8.86M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 29% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard S&P 500 ETF worth $18.3M.

  • Tower Research Capital (TRC)'s largest Q1 2025 buy was Vanguard S&P 500 ETF: 35,404 shares worth $18.3M.
  • Tower Research Capital (TRC) added most to Invesco QQQ Trust in Q1 2025, an estimated $274M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2025 reduction was Apple, cutting an estimated $126M.
  • Tower Research Capital (TRC) fully exited Listed Funds Trust Roundhill Magnificent Seven ETF in Q1 2025, selling an estimated $8.86M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3.36B portfolio in Q1 2025.
  • Tower Research Capital (TRC) opened 399 new positions and closed 947 in Q1 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 33% quarter-over-quarter to $3.36B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.